Tag: Drug pricing
Criticism from Industry Group on UK Drug Rebate Increase
U.K. Industry Group Criticizes Drug Rebate Increase ProposalA recent government proposal in the U.K. to raise mandatory rebates for drug companies aimed at supporting...
Analyzing UnitedHealth Buyouts and Drug Pricing Strategies
UnitedHealth Group recently made headlines with their announcement of buyout offers for employees working in the UnitedHealthcare insurance division. The company described the buyouts...
Maryland Lawmakers Vote to Expand Prescription Drug Affordability Board
In a groundbreaking move, Maryland lawmakers have cast a decisive vote to expand the powers of the Prescription Drug Affordability Board. This decision will...
Generic Drugmakers Prevail in California Pay-to-Delay Ban Battle
In a recent turn of events, a federal judge has ruled in favor of generic drugmakers in California's battle against pay-to-delay agreements. This controversial...
Threat to Pharmaceutical Public-Private Partnerships: Gilead’s Short-Term Win
In December 2024, a group of legal, medical, and public health experts united to file an amicus brief in support of the U.S. government...
Impact of U.S. Election on Medicare, Drug Pricing, and AI
Health care is a significant topic in the upcoming U.S. election, with leaders from different political backgrounds sharing their views on various health care...
New Title: Soft-Tissue Cancer Drug Approval and Zepbound Shortage Update: Pharmalittle News
Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a...
BREAKING NEWS
NYU School of Global Public Health Wins STAT Madness Vote
In a spirited celebration of scientific discovery, the recent STAT Breakthrough Summit East in Manhattan hosted a unique event that drew parallels to the...
